Výsledky vyhledávání - Gerald Schmid‐Bindert
- Zobrazuji výsledky 1 - 6 z 6
-
1
-
2
-
3
-
4
High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules Autor Chunyan Wu, Chao Zhao, Yang Yang, Yayi He, Likun Hou, Xuefei Li, Guanghui Gao, Jingyun Shi, Shengxiang Ren, Haiqing Chu, Caicun Zhou, Jun Zhang, Gerald Schmid‐Bindert
Vydáno 2015Artigo -
5
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1) Autor Suresh S. Ramalingam, Glenwood Goss, Rafael Rosell, Gerald Schmid‐Bindert, Bojan Zarić, Z. Andric, Igor Bondarenko, Д. В. Комов, Timur Cerić, Fadlo R. Khuri, Miroslav Samaržija, Enriqueta Felip, Tudor‐Eliade Ciuleanu, Vera Hirsh, S. Cindy, James Spicer, Ravi Salgia, Geoffrey I. Shapiro, Eric Sheldon, Florentina Teofilovici, Vojo Vukovic, Dean A. Fennell
Vydáno 2015Artigo -
6
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort Autor Oliver Gautschi, Julie Milia, Bastien Cabarrou, M.V. Bluthgen, Benjamin Besse, Egbert F. Smit, Juergen Wolf, Solange Peters, Martin Früh, Dieter Koeberle, Youssouf Oulkhouir, Martin Schüler, Alessandra Curioni‐Fontecedro, Benjamin Huret, M. Kerjouan, Sebastian Michels, Georg Pall, Sacha I. Rothschild, Gerald Schmid‐Bindert, Matthias Scheffler, Rémi Veillon, Luciano Wannesson, Joachim Diebold, Gérard Zalcman, Thomas Filleron, Julien Mazières
Vydáno 2015Artigo
Vyhledávací nástroje:
Související témata
Lung cancer
Medicine
Cancer
Internal medicine
Oncology
Biology
Adenocarcinoma
Colorectal cancer
Gene
KRAS
Mutation
Cancer research
Clinical trial
Genetics
Pathology
Targeted therapy
Adenocarcinoma of the lung
Biochemistry
Cabozantinib
Cell biology
Cell cycle
Chemistry
Chemotherapy
Clinical Practice
Cohort
Computed tomography
Concomitant
Confidence interval
Dabrafenib
Docetaxel